Litcius/Paper detail

Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update

Eli Muchtar, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Francis K. Buadi, Nelson Leung, Martha Q. Lacy, David Dingli, Sikander Ailawadhi, P. Leif Bergsagel, Rafaël Fonseca, Suzanne R. Hayman, Prashant Kapoor, Martha Grogan, Omar F. Abou Ezzeddine, Julie Rosenthal, Michelle L. Mauermann, Mustaqueem Siddiqui, Wilson I. Gonsalves, Taxiarchis Kourelis, Jeremy T. Larsen, Craig B. Reeder, Rahma Warsame, Ronald S. Go, David Murray, Ellen D. McPhail, Surendra Dasari, Dragan Jevremović, Robert A. Kyle, Yi Lin, John A. Lust, Stephen J. Russell, Yi L. Hwa, Amie Fonder, Miriam Hobbs, S. Vincent Rajkumar, Vivek Roy, Taimur Sher

2021Mayo Clinic Proceedings83 citationsDOI

Topics & Concepts

MedicineAL amyloidosisAmyloidosisOrgan dysfunctionIntensive care medicineMultiple myelomaInternal medicineImmunologyImmunoglobulin light chainAntibodySepsisAmyloidosis: Diagnosis, Treatment, OutcomesMyeloproliferative Neoplasms: Diagnosis and TreatmentDrug Transport and Resistance Mechanisms
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update | Litcius